Table of Contents
- EXECUTIVE SUMMARY
- A detailed and comprehensive overview of current financial position,
company strategy, product and pipeline analysis.
- THERAPEUTIC AREA FOCUS
- Key product analysis and forecasting
- Cardiovascular & Respiratory
- Anplag (sarpogrelate)
- Herbesser (diltiazem)
- Tanatril (imidapril)
- Neurology
- Ceredist (taltireline)
- Radicut (edavarone)
- Immunology & Inflammation
- Remicade (infliximab)
- Talion (bepotastine besilate)
- Gastrointestinal & Metabolism
- Urso (ursodeoxycholic acid)
- OPERATIONAL DATA
- A wealth of background and detail
- A full 5-year financial performance assessment
- Key corporate events
- Key agreements
- Infrastructure
- Subsidiaries and joint ventures
|
Related Report
|
View Cart
